1998
DOI: 10.1074/jbc.273.46.30675
|View full text |Cite
|
Sign up to set email alerts
|

Molecular Cloning of pTAC12 an Alternative Splicing Product of the CD3γ Chain as a Component of the Pre-T Cell Antigen-Receptor Complex

Abstract: We have reported that a 12-kDa molecule (pTAC12 as a pre-T cell receptor (TCR)-associated chain) was associated as a dimer with the pre-TCR complex as well as the clonotype-independent CD3 complex on the cell surface of immature thymocytes. We now report by protein sequencing and molecular cloning that pTAC12 is an alternatively spliced product of the CD3␥ chain lacking exon 4 containing the transmembrane region. The transcript of pTAC12 is expressed in most T cell lineages and parallels the expression of CD3␥… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

1999
1999
2011
2011

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 34 publications
(21 reference statements)
0
8
0
Order By: Relevance
“…Kendall and Thomas have shown suppression of endothelial cell growth factor activity by a secreted splice variant of vascular endothelial cell growth factor receptor lacking the transmembrane domain. 24 In addition, similar transmembrane-negative modifications generated by alternative splicing have been reported, e.g., for the T-cell receptor, 25 angiotensin-converting enzyme, 26 and interleukin-6 receptor. 27 Furthermore, the distinct functional role of such splicing variants was recently shown for the soluble receptor of advanced glycosylation, 28 which appears to be an important physiological mechanism regulating atherogenesis in hyperglycemia.…”
Section: Discussionmentioning
confidence: 99%
“…Kendall and Thomas have shown suppression of endothelial cell growth factor activity by a secreted splice variant of vascular endothelial cell growth factor receptor lacking the transmembrane domain. 24 In addition, similar transmembrane-negative modifications generated by alternative splicing have been reported, e.g., for the T-cell receptor, 25 angiotensin-converting enzyme, 26 and interleukin-6 receptor. 27 Furthermore, the distinct functional role of such splicing variants was recently shown for the soluble receptor of advanced glycosylation, 28 which appears to be an important physiological mechanism regulating atherogenesis in hyperglycemia.…”
Section: Discussionmentioning
confidence: 99%
“…The soluble nephrin could thus be involved in the regulation of the biological functions of nephrin. Such a mechanism is proposed for some other transmembrane proteins like the interleukin-6 receptor [18] and CD3g chain of pre-T-cell antigen receptor [19].…”
Section: Discussionmentioning
confidence: 99%
“…Examples of such secreted transmembrane-negative splicing variants, with biologically important regulation of the respective receptor affecting the ligand binding, include interleukin-6 receptor 25 and T cell receptor. 26 The exact role of nephrin-␣ in proteinuric diseases is currently being studied. Our preliminary results from the rat and mouse suggest that additional splicing of nephrin homologues may also occur in these species 27 at the transmembrane domain.…”
Section: Discussionmentioning
confidence: 99%